Checked against public sources on July 26, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
FDA recall appears in this brand's history. An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
| Vitamin D3 (as Cholecalciferol) | 50 mcg (2000 IU) 250% |
|---|---|
| Calcium (as Calcium Carbonate) | 40 mg 3% |
Printed on the package: USP VERIFIED · VITAMIN & SUPPLEMENT BRAND · Gluten Free · USP
We read 2 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
1 promise needs a closer look.
We found no named, citable study of this product or formula. The claim may rest on ingredient research rather than a trial of this product.
Headlines first. Open evidence only when you want the source trail.
An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
This recall is not about the product on this page. Pharmavite recalled a different product on June 6, 2016. FDA has since closed that case. The recalled item was “Nature Made(R) D3 1000IU, 125 count, UPC 0-31604-02793-3”. …
Locked evidence record →Open the full source-linked findingThe public ownership record is ambiguous. We show the exact candidates instead of choosing one by name similarity.
USPTO returned multiple live supplement-class records for the exact brand wordmark: PHARMAVITE LLC, PHARMAVITE CORPORATION. These records answer who owns registrations for the brand; the separate product-to-owner or manufacturer link remains open.
Locked evidence record →Open the full source-linked findingThe barcode matches, so we are checking the right product rather than a look-alike.
The brand's store lists this exact barcode as “Vitamin D3 2000 IU (50 mcg) Tablets” (variant: 400) — identity confirmed across retailer listings.
Locked evidence record →Open the full source-linked findingThese are evidence gaps, not strikes against the product.
These are the USPTO records behind the brand name. We show them all rather than choosing one by similarity.
CALIFORNIA, USA · Registration 3520080
8531 Fallbrook Avenue, West Hills, CALIFORNIA 91304, UNITED STATES
IC 005: dietary supplements.
CALIFORNIA, USA · Registration 1963505
8510 BALBOA BLVD., NORTHRIDGE, CALIFORNIA 91325, UNITED STATES
IC 005: vitamins, minerals and dietary supplements.
This answers who owns registrations for the brand wordmark. It does not by itself prove which entity made, imported, or sold this specific product. Open USPTO source ↗
$0.05 per labeled serving
matching UPC/GTIN · checked Jul 27, 2026
View on Amazon ↗$0.05 per labeled serving
matching UPC/GTIN · checked Jul 26, 2026
View on Target ↗$0.06 per labeled serving
matching UPC/GTIN · checked Jul 26, 2026
View on iHerb ↗$0.07 per labeled serving
matching UPC/GTIN · checked Jul 26, 2026
View on Brand website ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Same UPC/GTIN observed across 4 sellers. Amazon was lowest at $21.49; Brand website was highest at $26.79 — a $5.30 range at check time.
The observed listing and exact brand page repeat 50 mcg. That confirms cross-page consistency of the published claim, not the product contents.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built July 26, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.